RESULTS: A retrospective evaluation of all patients undergoing elective VA ablation at Ascension St Vincent Hospital from 1 January 2018 to 31 December 2019 was undertaken. Of those, the patients undergoing PVC ablation were divided into SDD and non-SDD. Patients underwent SDD at the discretion of the operator. The primary safety outcome was the 30-day incidence of complications and death. The primary efficacy outcome was procedural success. Among 188 patients who underwent VA ablation, 98 (52.1%) were PVC ablations, and of those, 55 (56.1%) were SDD. There was no difference in age, gender, comorbidities, or ejection fraction between the two groups. Patients that were non-SDD were more likely to be on chronic anticoagulation (P = 0.03), have ablation in the LV (P = 0.04), have retrograde access (P = 0.03), and receive heparin during the procedure (P = 0.01). There were no complications in the SDD group compared with one (2.3%) in the non-SDD group. There was no difference in primary efficacy between the two groups with a 90.9% acute success in the SDD and 88.4% in the non-SDD (P = 0.68).
CONCLUSIONS: Same-day discharge for CA of PVCs is feasible and could lower healthcare resource utilization without compromising outcomes in this unique population.
目的:评估接受室性早搏(PVC)选择性CA的患者当日出院(SDD)的有效性和安全性。
方法:对2018年1月1日至2019年12月31日在阿森松圣文森特医院接受择期VA消融术的所有患者进行回顾性评估。其中,将接受PVC消融的患者分为SDD和非SDD.根据操作者的判断,患者接受SDD。主要安全性结果是30天并发症和死亡的发生率。主要疗效结果是手术成功。
结果:在188例接受VA消融的患者中,98(52.1%)为PVC烧蚀,其中,55(56.1%)为SDD。年龄没有差异,性别,两组间合并症或射血分数。非SDD患者更有可能接受慢性抗凝治疗(p=0.03),在左心室有消融(p=0.04),有逆行通道(p=0.03),并在手术过程中接受肝素(p=0.01)。SDD组无并发症,非SDD组无并发症1例(2.3%)。两组之间的主要疗效没有差异,SDD的急性成功率为90.9%,非SDD的成功率为88.4%(p=0.68)。
结论:PVCs的CA当天出院是可行的,并且可以在不影响这一独特人群的结果的情况下降低医疗资源利用率。